Dataset from A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009265
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this multi-center event-driven study in participants with anemia associated
with chronic kidney disease (CKD) to evaluate the safety and efficacy of daprodustat.
创建时间：
2025-02-22
